Department of Periodontology, Kunming Medical University and Hospital of Stomatology, Kunming, China; Yunnan Key Laboratory of Stomatology, Kunming, China.
Department of Periodontology, Kunming Medical University and Hospital of Stomatology, Kunming, China; Yunnan Key Laboratory of Stomatology, Kunming, China.
Int Dent J. 2024 Apr;74(2):284-293. doi: 10.1016/j.identj.2023.09.005. Epub 2023 Oct 17.
Yunnan Baiyao (YNBY), a traditional Chinese medicine, is renowned for its anti-inflammatory properties. Recent studies have suggested that YNBY plays a significant role in inhibiting osteoclast differentiation and autophagy, which are essential processes in inflammation and bone resorption associated with periodontitis. However, the precise relationship between autophagy and the mechanism by which YNBY inhibits osteoclastogenesis remains unexplored.The primary objective of this study was to investigate the inhibitory effects of YNBY on the process of osteoclastogenesis and its potential in preventing inflammatory bone loss.
The animals were subjected to sacrifice at intervals of 2, 4, and 6 weeks postintervention whilst under deep anaesthesia, and specimens were subsequently collected. The specimens were subjected to hematoxylin and eosin (HE) staining, in addition to tartrate-resistant acid phosphatase (TRAP) staining and subsequently imaged employing a digital scanner. The confirmation of osteoclast (OC) differentiation and autophagic flux was achieved through various techniques, including western blotting, transmission electron microscopy (TEM), TRAP staining, pit formation assay, and immunofluorescence.
The microcomputed tomography images provided evidence of the effective inhibition of alveolar bone absorption at 2, 4, and 6 weeks following YNBY treatment. Additionally, the histomorphometric evaluations of tissue segments stained with HE and TRAP, which involved measuring the distance between the alveolar bone crest (ABC) and cementoenamel junction (CEJ) and quantifying TRAP-positive OCs, yielded comparable results to those obtained through computed tomography analysis. YNBY treatment resulted in a decrease in the CEJ-ABC distance and inhibition of OC differentiation. Furthermore, in vitro studies showed that the autophagy modulators rapamycin (RAP) and 3-methyladenine (3-MA) significantly affected OC differentiation and function. YNBY attenuated the impact of RAP on the differentiation of OCs, autophagy-related factor activation, and bone resorption.
We hypothesise that YNBY suppresses the differentiation of OC and bone resorption by blocking autophagy. This study reveals that targeting autophagy might be a new alternative treatment methodology for periodontitis treatment.
云南白药(YNBY)是一种中药,以其抗炎特性而闻名。最近的研究表明,YNBY 在抑制破骨细胞分化和自噬方面发挥着重要作用,而破骨细胞分化和自噬是与牙周炎相关的炎症和骨吸收的关键过程。然而,自噬与 YNBY 抑制破骨细胞生成的机制之间的确切关系尚未得到探索。本研究的主要目的是探讨 YNBY 对破骨细胞生成过程的抑制作用及其在预防炎症性骨丢失中的潜力。
动物在干预后 2、4 和 6 周的不同时间点进行安乐死,同时采集标本。对标本进行苏木精和伊红(HE)染色,以及抗酒石酸酸性磷酸酶(TRAP)染色,并随后使用数字扫描仪进行成像。通过western blot、透射电子显微镜(TEM)、TRAP 染色、陷窝形成试验和免疫荧光等多种技术来确认破骨细胞(OC)分化和自噬流的发生。
微计算机断层扫描图像显示 YNBY 治疗后 2、4 和 6 周时有效抑制了牙槽骨吸收。此外,对用 HE 和 TRAP 染色的组织段进行组织形态计量学评估,包括测量牙槽骨嵴(ABC)和牙骨质-釉质界(CEJ)之间的距离以及量化 TRAP 阳性 OC,得到的结果与计算机断层扫描分析结果相似。YNBY 治疗导致 CEJ-ABC 距离缩短和 OC 分化抑制。此外,体外研究表明,自噬调节剂雷帕霉素(RAP)和 3-甲基腺嘌呤(3-MA)显著影响 OC 分化和功能。YNBY 减弱了 RAP 对 OC 分化、自噬相关因子激活和骨吸收的影响。
我们假设 YNBY 通过阻断自噬来抑制 OC 分化和骨吸收。本研究表明,靶向自噬可能是治疗牙周炎的一种新的替代治疗方法。